Avadomide
Avadomide is an experimental cereblon E3 ligase modulator, or thalidomide analog that was discovered and studied by Celgene to see if it was effective against cancer. The deuterated S-enantiomer, SP-3164 is in development at Salarius Pharmaceuticals.